InvestorsHub Logo
icon url

crescentmotor

06/30/23 2:07 PM

#420899 RE: Gator328 #420895

I'm assuming a conservative year 1 target of 1000 treated patients with a focus on the US market.



I could go with that for a first-year estimate, but the market will be much more forward looking with its DCF projections.
icon url

abew4me

06/30/23 4:16 PM

#420938 RE: Gator328 #420895

Correct me if I'm wrong, but aren't most families with Rett children automatically covered by some kind of federal insurance program? (I can't imagine any family having to pay all of the special medical care that is required to raise a Rett child)

And if they are covered by a federal insurance program, wouldn't they automatically qualify to receive Blarcasimine once it is approved by the FDA?
icon url

gerry57

06/30/23 4:56 PM

#420953 RE: Gator328 #420895

I think the market size almost immediately will be 20% greater then soc expense now.